(Q46791572)

25 December 2017

title

Assessments of pharmacokinetic drug interactions and tolerability of albendazole, praziquantel and ivermectin combinations (English)

1 reference

25 December 2017

0 references

1 reference

1 reference

1

Na-Bangchang K

1 reference

25 December 2017

author name string

Kietinun S

2

1 reference

25 December 2017

Pawa KK

3

1 reference

25 December 2017

Hanpitakpong W

4

1 reference

25 December 2017

Na-Bangchang C

5

1 reference

25 December 2017

Lazdins J

6

1 reference

25 December 2017

publication date

2 November 2005

1 reference

25 December 2017

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

25 December 2017

volume

100

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

335-345

1 reference

25 December 2017

Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

The co-administration of ivermectin and albendazole--safety, pharmacokinetics and efficacy against Onchocerca volvulus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Phenytoin and carbamazepine decreased oral bioavailability of praziquantel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Anthelmintics. A comparative review of their clinical pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Clinical pharmacokinetics of anthelmintic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Safety, tolerability, and pharmacokinetics of escalating high doses of ivermectin in healthy adult subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

The epidemiology of acute adenolymphangitis due to lymphatic filariasis in northern Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

A high-performance liquid chromatographic method for determination of praziquantel in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Pharmacokinetic interaction between praziquantel and albendazole in Sudanese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Effects of a culturally congruent intervention on cognitive factors related to drug-use recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Pharmacokinetics of praziquantel in healthy volunteers and patients with schistosomiasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Effects of phenobarbital and 3-methylcholanthrene pretreatment on the pharmacokinetics of praziquantel in rats

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Ivermectin 400 micrograms/kg: long-term suppression of microfilariae in Bancroftian filariasis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Moderate to heavy infections ofTrichuris trichiuraaffect cognitive function in Jamaican school children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Fatalities after treatment of onchocerciasis with diethylcarbamazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Ivermectin in human medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Pharmacokinetic investigation of albendazole and praziquantel in Thai children infected with Giardia intestinalis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

A comparative study of the efficacy and tolerability of single and split doses of ivermectin and diethylcarbamazine in periodic brugian filariasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

A controlled chemotherapeutic intervention trial on the relationship between Ascaris lumbricoides infection and malnutrition in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Plasma levels of praziquantel decrease when dexamethasone is given simultaneously

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRSTMH.2005.05.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRSTMH.2005.05.017

1 reference

25 December 2017

1 reference

25 December 2017